EFTA00036889.txt Text dataset_8 View on DOJ

Illegal Activity
none
Blackmail
none
Date
2019-08-13
Document Type
email
Model
gemini-2.0-flash-001
Processed
2026-02-07T18:44
Summary
This email exchange discusses the mortality review for inmate Epstein and the updating of a supplement with Naloxone information at the Metropolitan Correctional Center. The participants are coordinating schedules and discussing the content of the supplement.
Metadata
Subject
Re: Fwd: 6031_03C.PATIENT CARE
Sender
Recipients
Document ID
6031_03C.PATIENT CARE
Date
2019-08-13
Relationships 1
Entity 1RelationshipEntity 2Description
CDR work Associate Warden CDR is communicating with the Associate Warden about the Mortality Review for inmate Epstien and updating the supplement.
Notable Quotes 2
Do you want to perform the Mortality Review for inmate Epstien this week? We have 30 days to complete the review.
We need to find time to review the attached Supplement to ensure it is up to date. I would like to add the Naloxone in it instead of creating a new Supplement just for Naloxone.
Public Knowledge
Context
The document discusses the Mortality Review for inmate Epstien, which is likely Jeffrey Epstein, and the updating of a supplement with Naloxone information. This would be of interest to media/journalists.
Media Worthy
Yes
Raw Analysis JSON click to expand
Themes
Communications/correspondenceLegal matters/litigation
People 3
Organizations 5
VerizonSamsung GalaxyMCC New YorkUSPHSMetropolitan Correctional Center
Locations 3
New YorkNew York New York 10007150 Park Row, New York, New York 10007
Text Analysis
Tone
Professional
Purpose
The email chain discusses the Mortality Review for inmate Epstien and updating a supplement with Naloxone information.
Significance
The document is significant because it discusses the Mortality Review for inmate Epstien, which is likely Jeffrey Epstein, and the updating of a supplement with Naloxone information.
File Info
File Name
EFTA00036889.txt
Dataset
dataset_8
Type
Text
Model
gemini-2.0-flash-001
Processed
2026-02-07T18:44:31.327697
DOJ Source
View on DOJ